Burnand Alice, Woodward Abi, Kantilal Kumud, Bhanu Cini, Jani Yogini, Orlu Mine, Rait Greta, Sajid Madiha, Samsi Kritika, Vickerstaff Victoria, Ward Jane, Wilcock Jane, Manthorpe Jill, Davies Nathan
Research Department of Primary Care and Population Health, Centre for Ageing Population Studies, University College London, London, United Kingdom.
Centre for Psychiatry and Mental Health, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.
Aging Ment Health. 2025 Aug;29(8):1407-1413. doi: 10.1080/13607863.2025.2481970. Epub 2025 Mar 24.
Dementia is a growing global health concern, significantly impacting primary care settings, where the majority of care for people with dementia is provided. Underserved and vulnerable groups, who often face disparities in access to care are at greater risk of this strain. Clinical pharmacists are well-positioned to provide care but their potential contribution to enhancing person-centred and inclusive care for people with dementia is largely unexplored. The aims are to explore the views and experiences of primary care based clinical pharmacists in providing inclusive care to people with dementia in the community.
We conducted 13 semi-structured interviews with primary care clinical pharmacists in England in 2023-2024, which were analysed using reflexive thematic analysis.
Two overarching themes were developed from the interviews: 1) involving patients in decision-making, ensuring person-centered care and 2) the prevalence of health inequalities and the impact on patient care.
Taking a personalised and person-centred approach clinical pharmacists can engage with patients and carers in decision-making. This can empower people, particularly those from minoritised or disadvantaged groups, to take an active role in their care. This may help with medication adherence but also build trust, potentially leading to better quality and more equitable care. Personalised care should consider cultural beliefs and preferences to reduce misunderstandings or stigma and improve the overall experience for individuals, helping to reduce disparities.
痴呆症是一个日益受到全球关注的健康问题，对初级保健机构产生了重大影响，而大多数痴呆症患者的护理都是在这些机构提供的。服务不足和弱势群体往往在获得护理方面面临差异，他们面临这种压力的风险更大。临床药剂师具备提供护理的良好条件，但他们对加强以患者为中心和包容性的痴呆症患者护理的潜在贡献在很大程度上尚未得到探索。目的是探讨社区中基于初级保健的临床药剂师在为痴呆症患者提供包容性护理方面的观点和经验。
2023 - 2024年，我们对英国的初级保健临床药剂师进行了13次半结构化访谈，并采用反思性主题分析法进行分析。
访谈形成了两个总体主题：1）让患者参与决策，确保以患者为中心的护理；2）健康不平等的普遍性及其对患者护理的影响。
采用个性化和以患者为中心的方法，临床药剂师可以让患者和护理人员参与决策。这可以增强人们的权能，特别是那些来自少数群体或弱势群体的人，使他们能够在自己的护理中发挥积极作用。这可能有助于提高用药依从性，还能建立信任，有可能带来更高质量、更公平的护理。个性化护理应考虑文化信仰和偏好，以减少误解或耻辱感，改善个人的整体体验，有助于减少差异。
